A systematic review of cost-effectiveness analyses of colorectal cancer screening in Europe: have studies included optimal screening intensities?
R Pokharel, YS Lin, E McFerran… - Applied Health Economics …, 2023 - Springer
Objective To assess the range of strategies analysed in European cost-effectiveness
analyses (CEAs) of colorectal cancer (CRC) screening with respect to the screening …
analyses (CEAs) of colorectal cancer (CRC) screening with respect to the screening …
Economic evaluations of screening strategies for the early detection of colorectal cancer in the average-risk population: A systematic literature review
J Mendivil, M Appierto, S Aceituno, M Comas, M Rue - PLoS One, 2019 - journals.plos.org
Background Colorectal cancer (CRC) screening has proven effective in reducing CRC
mortality. This study aimed to systematically review, and evaluate the reporting quality, of the …
mortality. This study aimed to systematically review, and evaluate the reporting quality, of the …
Cost-effectiveness of colorectal cancer screening
D Heresbach, S Manfrédi, B Branger… - … Clinique et Biologique, 2006 - europepmc.org
Colorectal cancer (CRC) screening in France is based on a faecal occult blood test every
two years in average risk subjects 50-74 years of age while other endoscopic or non …
two years in average risk subjects 50-74 years of age while other endoscopic or non …
Cost-effectiveness of population-based screening for colorectal cancer
JF O'mahony - British journal of cancer, 2013 - nature.com
Sharp et al's (2012) cost-effectiveness analysis (CEA) of colorectal screening in Ireland sees
the academic publication of a CEA published by Ireland's Health Information and Quality …
the academic publication of a CEA published by Ireland's Health Information and Quality …
Coût-efficacité du dépistage du cancer colorectal
D Heresbach, S Manfrédi, B Branger… - … clinique et biologique, 2006 - Elsevier
Colorectal cancer (CRC) screening in France is based on a faecal occult blood test every
two years in average risk subjects 50-74 years of age while other endoscopic or non …
two years in average risk subjects 50-74 years of age while other endoscopic or non …
Cost-effectiveness analysis of alternative colon cancer screening strategies in the context of the French national screening program
S Barré, H Leleu, R Benamouzig… - Therapeutic …, 2020 - journals.sagepub.com
Background: A nationwide colorectal cancer (CRC) screening program was set up in France
from 2009 for average-risk, asymptomatic people aged 50–74 years based on an …
from 2009 for average-risk, asymptomatic people aged 50–74 years based on an …
A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening
P van Gils, M van den Berg, H van Kranen… - European Journal of …, 2009 - Elsevier
Colorectal cancer screening is an effective public health strategy for decreasing colorectal
cancer mortality. Since many screening modalities exist, it needs to be determined what the …
cancer mortality. Since many screening modalities exist, it needs to be determined what the …
Cost-effectiveness of colorectal cancer screening in Slovakia
R Babela, A Orsagh, J Ricova… - European Journal of …, 2022 - journals.lww.com
Background Colorectal cancer (CRC) is an ideal disease for screening due to known and
detectable precursor lesions and slow progression from benign adenoma to invasive …
detectable precursor lesions and slow progression from benign adenoma to invasive …
Cost-effectiveness analysis of colorectal cancer screening: a systematic review
F Khalili, B Najafi, F Mansour-Ghanaei… - … and Healthcare Policy, 2020 - Taylor & Francis
Introduction Colorectal cancer (CRC) is a significant health problem with an increasing
incidence worldwide. Screening is one of the ways, in which cases and deaths of CRC can …
incidence worldwide. Screening is one of the ways, in which cases and deaths of CRC can …
Cost‐effectiveness of colorectal cancer screening strategies: A systematic review
Introduction Colorectal cancer (CRC) is the second leading cause of death worldwide and
the use of CRC screening tests can reduce the incidence and mortality of the disease by …
the use of CRC screening tests can reduce the incidence and mortality of the disease by …